Publications by authors named "Debendranath Dey"

Claim this Profile
O
Oxidized MIF is an Alzheimer's disease drug target relaying external risk factors to tau pathology.
Andreas Müller-Schiffmann, Felix Torres, Anatoliy Kitaygorodskyy, Anand Ramani, Argyro Alatza, Debendranath Dey

Cell Rep Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ALS assembly modulator signature in peripheral blood mononuclear cells: implications for ALS pathophysiology, therapeutics, and diagnostics.
Shao Feng Yu, Maya Michon, Anuradha F Lingappa, Kumar Paulvannan, Dennis Solas, Debendranath Dey

Clin Proteomics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule protein assembly modulators with pan-cancer therapeutic efficacy.
Anuradha F Lingappa, Olayemi Akintunde, Erin Samueli, Connie Ewald, Maya Michon, Debendranath Dey

Open Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex.
Maya Michon, Andreas Müller-Schiffmann, Anuradha F Lingappa, Shao Feng Yu, Li Du, Nicholas DeYarman, Debendranath Dey

Open Biol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Assembly Modulation: A New Approach to Amyotrophic Lateral Sclerosis (ALS) Therapeutics.
Shao Feng Yu, Kumar Paulvannan, Dennis Solas, Anuradha F Lingappa, Ana Raquel Moreira, Nicholas DeYarman, Debendranath Dey

J Exp Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pan-Respiratory Antiviral Chemotype Targeting a Host Multi-Protein Complex.
Maya Michon, Andreas Müller-Schiffmann, Anuradha F Lingappa, Shao Feng Yu, Li Du, Nicholas DeYarman, Debendranath Dey

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized clinical trial of BV-4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV-2 infections and its impact on inflammatory biomarkers.
Deepa Chitre, Satej Nadkarni, Namdev Jagtap, Rahul Tulle, Amol Gitte, Debendranath Dey

Phytother Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatoprotective Activity of BV-7310, a Proprietary Herbal Formulation of , , and , in Alcohol-Induced HepG2 Cells and Alcohol plus a Haloalkane, CCl, Induced Liver Damage in Rats.
Debendranath Dey, Sunetra Chaskar, Narendra Bhatt, Deepa Chitre

Evid Based Complement Alternat Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation.
Debendranath Dey, Sunetra Chaskar, Nitin Athavale, Deepa Chitre

Biomed Res Int· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets.
Rita Marreiros, Andreas Müller-Schiffmann, Verian Bader, Suganya Selvarajah, Debendranath Dey

Virus Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of LPS-induced TNF-α and NO production in mouse macrophage and inflammatory response in rat animal models by a novel Ayurvedic formulation, BV-9238.
Debendranath Dey, Sunetra Chaskar, Nitin Athavale, Deepa Chitre

Phytother Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-rabies virus protein-protein interactions as druggable antiviral targets.
Usha F Lingappa, Xianfu Wu, Amanda Macieik, Shao Feng Yu, Andy Atuegbu, Debendranath Dey

Proc Natl Acad Sci U S A· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARs.
Barbara Brunmair, Katrin Staniek, Zsuzsanna Lehner, Debendranath Dey, Charles W Bolten

Am J Physiol Cell Physiol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents.
Partha Neogi, Fredrick J Lakner, Satyanarayana Medicherla, Jin Cheng, Debendranath Dey

Bioorg Med Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential.
Debendranath Dey, Satya Medicherla, Partha Neogi, Maya Gowri, Jin Cheng

Metabolism· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis